GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qingdao Vland Biotech Co Ltd (SHSE:603739) » Definitions » EV-to-FCF

Qingdao Vland Biotech Co (SHSE:603739) EV-to-FCF : -326.06 (As of Mar. 26, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Qingdao Vland Biotech Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Qingdao Vland Biotech Co's Enterprise Value is ¥3,641 Mil. Qingdao Vland Biotech Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-11 Mil. Therefore, Qingdao Vland Biotech Co's EV-to-FCF for today is -326.06.

The historical rank and industry rank for Qingdao Vland Biotech Co's EV-to-FCF or its related term are showing as below:

SHSE:603739' s EV-to-FCF Range Over the Past 10 Years
Min: -617.49   Med: -35.61   Max: 2159.14
Current: -326.97

During the past 10 years, the highest EV-to-FCF of Qingdao Vland Biotech Co was 2159.14. The lowest was -617.49. And the median was -35.61.

SHSE:603739's EV-to-FCF is ranked worse than
100% of 415 companies
in the Biotechnology industry
Industry Median: 4.49 vs SHSE:603739: -326.97

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-26), Qingdao Vland Biotech Co's stock price is ¥13.41. Qingdao Vland Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.260. Therefore, Qingdao Vland Biotech Co's PE Ratio (TTM) for today is 51.58.


Qingdao Vland Biotech Co EV-to-FCF Historical Data

The historical data trend for Qingdao Vland Biotech Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Vland Biotech Co EV-to-FCF Chart

Qingdao Vland Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -67.50 -84.35 -11.20 -14.49 -67.05

Qingdao Vland Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -68.02 -67.05 -101.30 -631.07 -323.11

Competitive Comparison of Qingdao Vland Biotech Co's EV-to-FCF

For the Biotechnology subindustry, Qingdao Vland Biotech Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qingdao Vland Biotech Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Qingdao Vland Biotech Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Qingdao Vland Biotech Co's EV-to-FCF falls into.



Qingdao Vland Biotech Co EV-to-FCF Calculation

Qingdao Vland Biotech Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3641.112/-11.167
=-326.06

Qingdao Vland Biotech Co's current Enterprise Value is ¥3,641 Mil.
Qingdao Vland Biotech Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qingdao Vland Biotech Co  (SHSE:603739) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Qingdao Vland Biotech Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=13.41/0.260
=51.58

Qingdao Vland Biotech Co's share price for today is ¥13.41.
Qingdao Vland Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.260.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Qingdao Vland Biotech Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Qingdao Vland Biotech Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Qingdao Vland Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1318, Wangsha Road, Room 108, Enterprise Service Center, Chengyang District, Shandong, Qingdao, CHN, 266100
Qingdao Vland Biotech Co Ltd is a biotechnology company. The company is engaged in research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products.
Executives
Jia De Qiang Director
Chen Gang Director
Cao Cheng Director
Jiang Yong senior management
Xu Yong Supervisors

Qingdao Vland Biotech Co Headlines

No Headlines